Prognostic significance of peripheral blood S100A12, S100A8, and S100A9 concentrations in idiopathic pulmonary fibrosis

被引:1
|
作者
Ding, Dongyan [1 ]
Luan, Rumei [1 ]
Xue, Qianfei
Yang, Junling [1 ,2 ,3 ]
机构
[1] Second Hosp Jilin Univ, Dept Resp Med, Changchun, Peoples R China
[2] Univ Hosp Jilin Univ, Dept Resp Med, Changchun, Peoples R China
[3] Second Hosp Jilin Univ, 218 Ziqiang St, Changchun 130041, Jilin, Peoples R China
关键词
idiopathic pulmonary fibrosis (IPF); S100A12; S100A8; S100A9; Calgranulin; PROTEINS;
D O I
10.1016/j.cyto.2023.156387
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: S100A12, S100A8, and S100A9 are inflammatory disease biomarkers whose functional significance in idiopathic pulmonary fibrosis (IPF) remains unclear. We evaluated the significance of S100A12, S100A8, and S100A9 levels in IPF development and prognosis.Methods: The dataset was collected from the Gene Expression Omnibus (GEO) database and differentially expressed genes were screened using GEO2R. We conducted a retrospective study of 106 patients with IPF to explore the relationships between different biomarkers and poor outcomes. Pearson's correlation coefficient, Kaplan-Meier, Cox regression, and functional enrichment analyses were used to evaluate relationships between these biomarkers' levels and clinical parameters or prognosis.Results: Serum levels of S100A12, S100A8, and S100A9 were significantly elevated in patients with IPF. The two most significant co-expression genes of S100A12 were S100A8 and S100A9. Patients with levels of S100A12 (median 231.21 ng/mL), S100A9 (median 57.09 ng/mL) or S100A8 (median 52.20 ng/mL), as well as combined elevated S100A12, S100A9, and S100A8 levels, exhibited shorter progression-free survival and overall survival. Serum S100A12 and S100A8, S100A12 and S100A9, S100A9 and S100A8 concentrations also displayed a strong positive correlation (r(s)(2) = 0.4558, r(s)(2) = 0.4558, r(s)(2) = 0.6373; P < 0.001). S100A12 and S100A8/9 concentrations were independent of FVC%, DLCO%, and other clinical parameters (age, laboratory test data, and smoking habit). Finally, in multivariate analysis, the serum levels of S100A12, S100A8, and S100A9 were significant prognostic factors (hazard ratio 1.002, P = 0.032, hazard ratio 1.039, P = 0.001, and hazard ratio 1.048, P = 0.003).Conclusions: S100A12, S100A8, and S100A9 are promising circulating biomarkers that may aid in determining IPF patient prognosis. Multicenter clinical trials are needed to confirm their clinical value.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Neurodegenerative effects of S100A8 and S100A9 in Parkinson's disease
    Lee, J. S.
    Kashif, A.
    Kim, G.
    Hong, M. H.
    Kim, I. S.
    FEBS OPEN BIO, 2022, 12 : 199 - 199
  • [32] Regulation of myeloid cell differentiation by S100A8 and S100A9
    Defrene, J.
    Laouedj, M.
    Cesaro, A.
    Page, N.
    Barabe, F.
    Tessier, P.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 322 - 322
  • [33] Crosslinking of microtubules and actin filaments by S100A8/S100A9
    M Wolf
    C Riethmüller
    B Petersen
    H Oberleithner
    J Roth
    T Vogl
    Cell Communication and Signaling, 7 (Suppl 1)
  • [34] The role of S100A8, S100A9 and Calprotectin in skin inflammation
    Irigoyen, M. Palomo
    Bakiri, L.
    Wagner, E. F.
    FEBS OPEN BIO, 2022, 12 : 39 - 39
  • [35] S100A8 and S100A9: New Insights into Their Roles in Malignancy
    Srikrishna, Geetha
    JOURNAL OF INNATE IMMUNITY, 2012, 4 (01) : 31 - 40
  • [36] The role of S100A8, S100A9 and Calprotectin in skin inflammation
    Irigoyen, M. P.
    Bakiri, L.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 6 - 7
  • [37] SenoIndex: S100A8/S100A9 as a novel aging biomarker
    Zhang, Baohu
    Yan, Haoteng
    Liu, Xiaoqian
    Sun, Liang
    Ma, Shuai
    Wang, Si
    Qu, Jing
    Liu, Guang-Hui
    Zhang, Weiqi
    LIFE MEDICINE, 2023, 2 (04):
  • [38] S100A8 and S100A9 positive cells in colorectal carcinoma
    Bassorgun, C. I.
    Ozluk, A.
    Erin, N.
    Uzun, O. C.
    Elpek, G. O.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 209 - 209
  • [39] S100A8 & S100A9: Alarmin mediated inflammation in tendinopathy
    Crowe, Lindsay A. N.
    McLean, Michael
    Kitson, Susan M.
    Melchor, Emma Garcia
    Patommel, Katharina
    Cao, Hai Man
    Reilly, James H.
    Leach, William J.
    Rooney, Brain P.
    Spencer, Simon J.
    Mullen, Michael
    Chambers, Max
    Murrell, George A. C.
    McInnes, Iain B.
    Akbar, Moeed
    Millar, Neal L.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [40] S100A8 & S100A9: Alarmin Mediated Inflammation in Tendinopathy
    Crowe, Lindsay A. N.
    McLean, Michael
    Garcia-Melchor, Emma
    Patommel, Katharina
    Kitson, Susan M.
    Reilly, James H.
    McInnes, Iain B.
    Akbar, Moeed
    Millar, Neal L.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70